JACTAX LD Drug Eluting Stent Trial

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

July 31, 2010

Conditions
Coronary Artery Disease
Interventions
DEVICE

JACTAX LD DES

Drug Eluting Stent

DEVICE

TAXUS™ Libertè™ DES

Drug Eluting Stent

Trial Locations (5)

Unknown

Universitatsklinikum Bonn, Bonn

Cardiovascular Center Sankt Katharinen, Frankfurt

Hamburg University CardioVascular Center, Hamburg

HELIOS Klinikum, Siegburg

Krankenhaus der Barmherzigen Bruder, Trier

Sponsors
All Listed Sponsors
collaborator

Labcoat, Ltd.

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY

NCT00754975 - JACTAX LD Drug Eluting Stent Trial | Biotech Hunter | Biotech Hunter